_version_ 1818588556068651008
author Hosseini-Tabatabaei Azadeh
Esmaily Hadi
Rahimian Reza
Khorasani Reza
Baeeri Maryam
Barazesh-Morgani Ahmadreza
Sari-Aslani Fatemeh
Abdollahi Mohammad
author_facet Hosseini-Tabatabaei Azadeh
Esmaily Hadi
Rahimian Reza
Khorasani Reza
Baeeri Maryam
Barazesh-Morgani Ahmadreza
Sari-Aslani Fatemeh
Abdollahi Mohammad
author_sort Hosseini-Tabatabaei Azadeh
collection DOAJ
first_indexed 2024-12-16T09:26:38Z
format Article
id doaj.art-724a41ed09894626befb2d7284146837
institution Directory Open Access Journal
issn 2391-5412
language English
last_indexed 2024-12-16T09:26:38Z
publishDate 2009-03-01
publisher De Gruyter
record_format Article
series Open Life Sciences
spelling doaj.art-724a41ed09894626befb2d72841468372022-12-21T22:36:38ZengDe GruyterOpen Life Sciences2391-54122009-03-0141748510.2478/s11535-008-0047-0Benefit of nicorandil using an immunologic murine model of experimental colitisHosseini-Tabatabaei Azadeh0Esmaily Hadi1Rahimian Reza2Khorasani Reza3Baeeri Maryam4Barazesh-Morgani Ahmadreza5Sari-Aslani Fatemeh6Abdollahi Mohammad7Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, 1417614411, IranFaculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, 1417614411, IranSchool of Medicine, Tehran University of Medical Sciences, Tehran, 1417614411, IranFaculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, 1417614411, IranFaculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, 1417614411, IranFaculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, 1417614411, IranSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, 71345, IranFaculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, 1417614411, Iranhttps://doi.org/10.2478/s11535-008-0047-0nicorandilinflammatory bowel diseaseimmunologicmyeloperoxidaseinflammatory cytokines2,4,6-trinitrobenzene sulphonic acid (tnbs)
spellingShingle Hosseini-Tabatabaei Azadeh
Esmaily Hadi
Rahimian Reza
Khorasani Reza
Baeeri Maryam
Barazesh-Morgani Ahmadreza
Sari-Aslani Fatemeh
Abdollahi Mohammad
Benefit of nicorandil using an immunologic murine model of experimental colitis
Open Life Sciences
nicorandil
inflammatory bowel disease
immunologic
myeloperoxidase
inflammatory cytokines
2,4,6-trinitrobenzene sulphonic acid (tnbs)
title Benefit of nicorandil using an immunologic murine model of experimental colitis
title_full Benefit of nicorandil using an immunologic murine model of experimental colitis
title_fullStr Benefit of nicorandil using an immunologic murine model of experimental colitis
title_full_unstemmed Benefit of nicorandil using an immunologic murine model of experimental colitis
title_short Benefit of nicorandil using an immunologic murine model of experimental colitis
title_sort benefit of nicorandil using an immunologic murine model of experimental colitis
topic nicorandil
inflammatory bowel disease
immunologic
myeloperoxidase
inflammatory cytokines
2,4,6-trinitrobenzene sulphonic acid (tnbs)
url https://doi.org/10.2478/s11535-008-0047-0
work_keys_str_mv AT hosseinitabatabaeiazadeh benefitofnicorandilusinganimmunologicmurinemodelofexperimentalcolitis
AT esmailyhadi benefitofnicorandilusinganimmunologicmurinemodelofexperimentalcolitis
AT rahimianreza benefitofnicorandilusinganimmunologicmurinemodelofexperimentalcolitis
AT khorasanireza benefitofnicorandilusinganimmunologicmurinemodelofexperimentalcolitis
AT baeerimaryam benefitofnicorandilusinganimmunologicmurinemodelofexperimentalcolitis
AT barazeshmorganiahmadreza benefitofnicorandilusinganimmunologicmurinemodelofexperimentalcolitis
AT sariaslanifatemeh benefitofnicorandilusinganimmunologicmurinemodelofexperimentalcolitis
AT abdollahimohammad benefitofnicorandilusinganimmunologicmurinemodelofexperimentalcolitis